Funding for this research was provided by:
Giovanni Armenise-Harvard Foundation (CDA)
Ministero della Salute (COVID-2020-12371849, Ricerca Corrente 2021, Ricerca Corrente)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (No. 75N93021C00016)
Received: 18 January 2022
Accepted: 10 August 2022
First Online: 22 September 2022
: A.Sette is a consultant for Gritstone Bio, Flow Pharma, Arcturus Therapeutics, ImmunoScape, CellCarta, Avalia, Moderna, Fortress and Repertoire. All other authors declare no conflicts of interest. L.J.I. has filed for patent protection for various aspects of T cell epitope and vaccine design work. CCI. has filed a patent for immune correlate of protection after RNA vaccination. R.D.F. is a consultant for Moderna Inc. The data are tabulated in the main paper and in the supplementary materials.
Free to read: This content has been made available to all.